Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S393000
Reexamination Certificate
active
07902209
ABSTRACT:
Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.
REFERENCES:
patent: RE24906 (1960-12-01), Ulrich
patent: 3700674 (1972-10-01), Diehl et al.
patent: 4013665 (1977-03-01), Crenshaw et al.
patent: 4052393 (1977-10-01), Treuner
patent: 4191767 (1980-03-01), Warner, Jr. et al.
patent: 4197403 (1980-04-01), Warner, Jr. et al.
patent: 4411893 (1983-10-01), Johnson et al.
patent: 4601856 (1986-07-01), Suzuki et al.
patent: 4686125 (1987-08-01), Johnston et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4695465 (1987-09-01), Kigasawa et al.
patent: 4698348 (1987-10-01), Gerster
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4746515 (1988-05-01), Cheng et al.
patent: 4751087 (1988-06-01), Wick
patent: 4863970 (1989-09-01), Patel et al.
patent: 4908389 (1990-03-01), Mahjour et al.
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5008110 (1991-04-01), Benecke et al.
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gester
patent: 5300291 (1994-04-01), Sablotsky et al.
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5472982 (1995-12-01), Suzuki
patent: 5482936 (1996-01-01), Lindstrom
patent: 5532030 (1996-07-01), Hirose et al.
patent: 5736553 (1998-04-01), Wick et al.
patent: 5756747 (1998-05-01), Gerster
patent: 5919815 (1999-07-01), Bradley et al.
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6103697 (2000-08-01), Bergstrand et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6210712 (2001-04-01), Edgren et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6267957 (2001-07-01), Green et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6425776 (2002-07-01), Fredl et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6498261 (2002-12-01), Ewbank et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6559182 (2003-05-01), Purcell
patent: 6562363 (2003-05-01), Mantelle et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6638528 (2003-10-01), Kanios
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6756382 (2004-06-01), Coleman et al.
patent: 6797718 (2004-09-01), Dellaria et al.
patent: 6803420 (2004-10-01), Cleary et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 7056528 (2006-06-01), Bracht et al.
patent: 7504114 (2009-03-01), Kurita et al.
patent: 2002/0128345 (2002-09-01), Paul
patent: 2003/0026794 (2003-02-01), Fein
patent: 2003/0059471 (2003-03-01), Compton et al.
patent: 2003/0072814 (2003-04-01), Maibach et al.
patent: 2003/0096012 (2003-05-01), Besse et al.
patent: 2003/0124191 (2003-07-01), Besse et al.
patent: 2003/0170308 (2003-09-01), Cleary et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski et al.
patent: 2003/0211163 (2003-11-01), Chong
patent: 2004/0089855 (2004-05-01), Oommen et al.
patent: 2004/0091491 (2004-05-01), Kedl et al.
patent: 2004/0132766 (2004-07-01), Griesgraber
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0192585 (2004-09-01), Owens et al.
patent: 2004/0242770 (2004-12-01), Feldstein et al.
patent: 2005/0037030 (2005-02-01), Kumar et al.
patent: 2005/0175630 (2005-08-01), Raz et al.
patent: 2005/0201959 (2005-09-01), David
patent: 2005/0276842 (2005-12-01), Zhang et al.
patent: 2005/0281772 (2005-12-01), Bromley et al.
patent: 2006/0024243 (2006-02-01), Arkin et al.
patent: 2006/0034779 (2006-02-01), Arkin et al.
patent: 2006/0039931 (2006-02-01), Scheiwe et al.
patent: 2007/0167479 (2007-07-01), Busch et al.
patent: 0 107 455 (1984-05-01), None
patent: 0 187 705 (1986-07-01), None
patent: 0 394 026 (1990-10-01), None
patent: 0 582 581 (1999-05-01), None
patent: 1 512 685 (2006-07-01), None
patent: P0002103-AB (2000-10-01), None
patent: 61-00297 A (1986-01-01), None
patent: 62-148449 A (1987-07-01), None
patent: 05-246948 A (1993-09-01), None
patent: 07-138145 A (1995-05-01), None
patent: 76145 (1983-02-01), None
patent: 76045 (1995-12-01), None
patent: 88/09676 (1988-12-01), None
patent: WO 92/15582 (1992-09-01), None
patent: WO-01/06829 (2001-02-01), None
patent: WO-01/07009 (2001-02-01), None
patent: WO-2004/024126 (2004-03-01), None
patent: WO-2004/037201 (2004-05-01), None
patent: WO-2005/020995 (2005-03-01), None
patent: WO-2005/020999 (2005-03-01), None
patent: WO-2005/067897 (2005-07-01), None
patent: WO-2005/074894 (2005-08-01), None
patent: WO-2005/079143 (2005-09-01), None
patent: WO-2005/089317 (2005-09-01), None
patent: WO 2006/074046 (2006-07-01), None
patent: WO 2008/010963 (2008-01-01), None
Loftsson et al., “The Effect of Vehicle Additives on the Transdermal Delivery of Nitroglycerin,” Pharmaceutical Research, vol. 4:5, 1987, pp. 436-437.
Croda, “Super Refined Oleic Acid NF”, Pharmaceutical & Nutritional, PN-38, 2002, pp. 1-4.
Chollet et al., “Development of a Topically Active Imiquimod Formulation”, Pharmaceutical Development and Technology, 4(1), pp. 35-43 (1999).
Goliath et al., “Super Refined Oleic Acid Available from Croda”, Household & Personal Products Industry, http://goliath.ecnext.com, pp. 1-2.
USP Material Safety Data Sheet, “Oleic Acid”, Catalog No. 1478130, U.S. Pharmacopeia, pp. 1-6 (2004).
USP Certificate—Oleic Acid LOT F0E001, CAT. No. 1478130.
Amendment and Response to U.S. Appl. No. 07/845,323.
2008 USPC Official Dec. 1, 2007-Apr. 30, 2008—NF Monographs: Oleic Acid.
Household & Personal Products Industry: Super refined oleic acid available from Croda, Feb. 1, 2003.
Lashmar, et al. J. Pharm. Pharmacol. 1989, Topical Application of Penetration Enhancers to the Skin of Nude Mice: A Histopathological Study; vol. 41:118-121.
Croda—Super Refined Oleic Acid NF.
Naik et al., “Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans”,Journal of Controlled Release, vol. 37, pp. 299-306 (1995).
Green et al., “In vitro and in vivo enhancement of skin permeation with oleic and lauric acids”,International Jounal of Pharmaceutics, vol. 48, pp. 103-111 (1988).
Yamashita et al., “Analysis of in vivo skin penetration enhancement by oleic acid based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum”,International Journal of Pharmaceutics, vol. 117, pp. 173-179 (1995).
Yamane et al., “Effects of terpenes and oleic acid as skin penetration enhnacers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry”,International Journal of Pharmaceutics, vol. 116, pp. 237-251 (1995).
Meshulam et al., “Transdermal penetration of physostigmine: Effects of oleic acid enhancer”,Drug Development Research, vol. 28, pp. 510-515 (1993).
Kim et al., “Enhanced bioavailability of aceclofenac using solid dispersions: bioequivalence test of capsule and tablet with different doses in human volunteers”,Controlled Release Society 29th Annual Meeting Proceedings, pp. 730-731
Nelson Robert J.
Statham Alexis S.
3M Innovative Proerties Company
Claytor Renee
Edwards Angell Palmer & & Dodge LLP
Manso Peter J.
Padmanabhan Sreeni
LandOfFree
Method of preparing a pharmaceutical cream and minimizing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing a pharmaceutical cream and minimizing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing a pharmaceutical cream and minimizing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2751118